Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjunctivitis

Am J Ophthalmol. 1986 Mar 15;101(3):283-7. doi: 10.1016/0002-9394(86)90820-2.

Abstract

We successfully treated two patients with severe Staphylococcus epidermidis blepharoconjunctivitis by means of a topical vancomycin hydrochloride solution (50 mg/ml) prepared with sterile water. Aqueous vancomycin preparations, however, cause significant ocular irritation probably because of low pH and osmolality values. Solutions prepared with normal saline (5 mg/ml) and phosphate-buffered artificial tears (5 mg/ml and 50 mg/ml) were significantly less irritating and possessed equivalent in vitro antimicrobial activity. Topical vancomycin should be used only when commercially available antibiotics are inadequate.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Aged
  • Blepharitis / drug therapy
  • Blepharitis / etiology*
  • Conjunctivitis / drug therapy
  • Conjunctivitis / etiology*
  • Drug Evaluation
  • Eyelid Diseases / etiology*
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Methicillin*
  • Ophthalmic Solutions
  • Osmolar Concentration
  • Penicillin Resistance
  • Staphylococcal Infections*
  • Staphylococcus epidermidis
  • Vancomycin / administration & dosage*
  • Vancomycin / therapeutic use

Substances

  • Ophthalmic Solutions
  • Vancomycin
  • Methicillin